Standout Papers
Citation Impact
Citing Papers
Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans
2011
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
2010 StandoutScience
Genetic Influences on Brain Gene Expression in Rats Selected for Tameness and Aggression
2014 StandoutNobel
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
2007
T3Augmentation in Major Depressive Disorder: Safety Considerations
2011
Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder
2010
Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol
2011
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
2015
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder
2009
Sleep and mental disorders: A meta-analysis of polysomnographic research.
2016
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
2015
2012
Gender differences in depression: Findings from the STAR*D study
2005
Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
2017
Relapse Following Successful Electroconvulsive Therapy for Major Depression: A Meta-Analysis
2013
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007 Standout
Major depressive disorder: new clinical, neurobiological, and treatment perspectives
2011
Tools and Strategies for Ongoing Assessment of Depression
2009
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: major depression summary
2018
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Antidepressant Drug Effects and Depression Severity
2010 Standout
The Indiana Cancer Pain and Depression (INCPAD) trial
2009
Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents
2007
Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release
2006
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
2014
A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment
2014
Rapid Mood-Elevating Effects of Low Field Magnetic Stimulation in Depression
2013
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Clinical and Demographic Factors Associated With DSM-IV Melancholic Depression
2006
Altered fecal microbiota composition in patients with major depressive disorder
2015 Standout
Remissions in maternal depression and child psychopathology: a STAR*D-child report.
2006
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
2018 Standout
A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients
2006
Venlafaxine Extended-Release
2001
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
2014
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies
2013
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D
2004
Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal Pain
2009
Attachment and social adjustment: Relationships to suicide attempt and major depressive episode in a prospective study
2009
Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics
2003
Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder
2011
Depression
2018 Standout
Chronic Depression
2005
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial
2016
Remission of Maternal Depression: Relations to Family Functioning and Youth Internalizing and Externalizing Symptoms
2008
Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial
2008
Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder
2006
Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment
2007
S -Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial
2010
Major depressive disorder
2016 Standout
Identification of 15 genetic loci associated with risk of major depression in individuals of European descent
2016
Effects of Citalopram and Interpersonal Psychotherapy on Depression in Patients With Coronary Artery Disease
2007
Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study
2007
Recent Evidence Linking Coronary Heart Disease and Depression
2006
An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report
2005
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression
2011
The neurobiological consequences of early stress and childhood maltreatment
2003
Child abuse: Adolescent records vs. adult recall
1990 Standout
The Serotonin-1A Receptor in Anxiety Disorders
2009
Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy
2012
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
2005
Riluzole in the Treatment of Mood and Anxiety Disorders
2008
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms
2011
Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors
2007
Abuse, Trauma, and GI Illness: Is There a Link?
2010
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
2008
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Novel Drugs and Therapeutic Targets for Severe Mood Disorders
2008
Prospective Assessment of Stereotactic Ablative Surgery for Intractable Major Depression
2008
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole
2008
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study
2008
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
2010 Standout
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial
2015
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
2007
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
2015
Psychedelics Promote Structural and Functional Neural Plasticity
2018
Are child-, adolescent-, and adult-onset depression one and the same disorder?
2001
What Happened to Lithium? Antidepressant Augmentation in Clinical Settings
2006
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Restoring melancholia in the classification of mood disorders
2007
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines
2004
Brief Intervention for Anxiety in Primary Care Patients
2009
Burden and consequences of child maltreatment in high-income countries
2008 Standout
Genetic Regulation of Behavioral and Neuronal Responses to Fluoxetine
2007
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
2008
Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression
2008
Self-harm and suicide in adolescents
2012 Standout
Reducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy's effects.
2007
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Clinical Results for Patients With Major Depressive Disorder in theTexas Medication Algorithm Project
2004
A Computerized Decision Support System for Depression in Primary Care
2009
The Antidepressive Effects of Exercise
2009
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe
2016
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
2012
Sex differences in antidepressant efficacy
2018
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
2008
Depression in adolescence
2012 Standout
Current understanding of the human microbiome
2018 Standout
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Transcranial direct current stimulation (tDCS) in the treatment of depression: Systematic review and meta-analysis of efficacy and tolerability
2015
Major Depressive Disorder
2008 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Decline in Cardiorespiratory Fitness and Odds of Incident Depression
2012
Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies
2009
AKT/PKB Signaling: Navigating the Network
2017 Standout
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression
2009
Augmentation strategies for treatment-resistant depression
2008
Repetition of suicide attempts across episodes of severe depression Behavioural sensitisation found in suicide group but not in controls
2011
Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review
2016
Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
2005
Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: Effects of fluoxetine and MK-801
2011
The use of psychotropic drugs in irritable bowel syndrome
2013
The molecular neurobiology of depression
2008 StandoutNature
Enhanced Depression Care for Patients With Acute Coronary Syndrome and Persistent Depressive Symptoms
2010
Are students prone to depression and suicidal thoughts?
2013
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
Somatoform Disorders and Recent Diagnostic Controversies
2007
Irritable Bowel Syndrome
2015 Standout
The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects
2007
Is treatment-resistant depression a useful concept?
2016
Developmental neurobiology of childhood stress and trauma
2002
Care Management of Poststroke Depression
2007
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
A Model of Placebo Response in Antidepressant Clinical Trials
2013
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Prevalence of Depression, Depressive Symptoms, and Suicidal Ideation Among Medical Students
2016 Standout
Dual–Dual Action? Combining Venlafaxine and Mirtazapine in the Treatment of Depression
2008
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors.
1996 StandoutNobel
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
ANXIOUS FORMS OF DEPRESSION
2013
ChatGPT: five priorities for research
2023 StandoutNature
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs
2010
The depression market
2011
Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study
2012
Depression and Coronary Heart Disease
2008 Standout
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
2006
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Beyond Tricyclics
2009
What Happened to Lithium? Antidepressant Augmentation in Clinical Settings
2006
Definition, Assessment, and Staging of Treatment—Resistant Refractory Major Depression: A Review of Current Concepts and Methods
2007
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
2018
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study
2007
Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
2000 Standout
Cost burden of treatment resistance in patients with depression.
2010
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Works of Michael E. Thase being referenced
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Effect of Age at Onset on the Course of Major Depressive Disorder
2007
Treatment of SSRI-Resistant Depression: A Meta-Analysis Comparing Within- Versus Across-Class Switches
2007
Tranylcypromine Versus Venlafaxine Plus Mirtazapine Following Three Failed Antidepressant Medication Trials for Depression: A STAR*D Report
2006
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
2006
The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder
2008
Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study
2003
Chronic forms of major depression are still undertreated in the 21st century: Systematic assessment of 801 patients presenting for treatment
2008
Does the Duration of Index Episode Affect the Treatment Outcome of Major Depressive Disorder?
2008
Can Phase III Trial Results of Antidepressant Medications Be Generalized to Clinical Practice? A STAR*D Report
2009
Managing depressive and anxiety disorders with escitalopram
2006
Psychotherapy and Medication in the Treatment of Adult and Geriatric Depression
2005
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
2006
Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants
2009
Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D
2008
Citalopram treatment of paroxetine-intolerant depressed patients
2002
Prefrontal and Cerebellar Abnormalities in Major Depression: Evidence from Oculomotor Studies
1998
Molecules That Mediate Mood
2007
Measurement of 5‐HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY‐100635
2007
Correlation of nocturnal penile tumescence and daytime affect intensity in depressed men
1993
Antidepressant Options: Venlafaxine in Perspective
1996
Reply to Amitriptyline: Dual-Action Antidepressant?
2003
Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.
1989
Methodology to measure onset of action.
2001
What To Do with SSRI Nonresponders?
1999